A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)
Clinical trial NCT04880161 · COMPLETED
Trial details
- NCT number
- NCT04880161
- Sponsor
- Ampio Pharmaceuticals. Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2021-12-22
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.